Molson Coors doubles down on premium, innovative drinks amid beer demand decline

Company’s innovation efforts include cannabis-infused beverages

Molson Coors Brewing Co. plans to continue focusing on offering more premium and innovative drinks, including a soon-to-be launched line of cannabis-infused beverages, as it grapples with declining beer demand in North America.

“Consumers are drinking slightly less, but better,” said CEO Mark Hunter during a conference call with analysts Tuesday after the company released its fourth-quarter financial results.

The company must accelerate premiumization of its portfolio and innovation agenda, he said.

It’s doubling down on efforts to promote several brands, including Blue Moon — a craft brand that Molson plans to double its media spend on in the United States. The brand is called Belgian Moon in Canada.

Hunter also outlined some of the company’s innovation efforts, including cannabis-infused beverages.

The company expects Truss, a joint venture with Hexo Corp., to launch a portfolio of cannabis-infused beverages this autumn. The federal government has said it will legalize edibles by Oct. 17.

Molson, which keeps its books in U.S. dollars, is over delivering on its cost-savings plans for 2017-19, which is partly insulating the company from weaker industry demand in North America, among other industry challenges, Hunter said.

The company also restated its financial results for 2016 and 2017 due to income tax accounting errors.

For 2016, it understated its deferred tax liability and income tax expense which resulted in an overstatement of its net income by $399.1 million.

However, the deferred tax liability required revaluation in 2017 due to U.S. tax changes and that resulted in an overstatement of its income tax expense and understatement of its net income of $151.4 million for the year.

The company reported a fourth-quarter profit of $76 million or 35 cents per diluted share for the three months ended Dec. 31 compared with a profit of $716.9 million or $3.31 per diluted share a year earlier.

Its underlying profit for the quarter amounted to $182.3 million or 84 cents per diluted share, up from $134.3 million or 62 cents per share a year earlier.

Net sales totalled $2.42 billion, down from $2.58 billion.

Molson Coors shares were down $5.99 or 6.8 per cent at $82.01 in afternoon trading on the Toronto Stock Exchange.

Just Posted

Body of 19-year-old drowning victim recovered from Sylvan Lake

RCMP say the body was recovered the evening of Aug. 22.

UPDATED: Search continues for possible drowning on Sylvan Lake

Sylvan Lake RCMP and Fire Department continue their search for 20-something adult male

Trial date set for Sylvan Lake doctor charged with child sex offences

Janke will stand trial next November in Edmonton

UPDATED: RCMP and fire departments respond to possible drowning on Sylvan Lake

RCMP say they are actively searching for a man in his 20s with boats on the lake

Red Deer-Lacombe MP Calkins comments on CPC promise to make maternity benefits tax free

Tax credit would remove federal income tax from EI maternity and EI parental benefits

Trudeau vows to stand firm against ‘increasingly assertive’ China

China has accused Canada of meddling in its affairs

Black bear ruins Alberta barber’s day

It’s not always a good idea to leave the door open

Conan turns to the Property Brothers for tips on buying Greenland

Jonathan Scott suggests removing glaciers and mountains to bring in ‘more natural light’

Red Deer Rebels Training Camp begins Aug. 24

Rebels home opener will be on Sept. 21 against the Edmonton Oil Kings

New study suggests autism overdiagnosed: Canadian expert

Laurent Mottron: ‘Autistic people we test now are less and less different than typical people’

Huawei executive’s defence team alleges Canadians were ‘agents’ of the FBI

eng’s arrest at Vancouver’s airport has sparked a diplomatic crisis between Canada and China

Trans Mountain gives contractors 30 days to get workers, supplies ready for pipeline

Crown corporation believes the expansion project could be in service by mid-2022

On vaccines, abortion, Goop, doctor Jen Gunter says: ‘I have a duty to speak up’

She speaks out on menstruation, the wellness industry and vaccines

Most Read